AzTrials
AzTrials

Achilles TendinopathyNCT04725513

Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy

A study testing Shockwave Therapy, Photobiomodulation Therapy and Physical Therapy in people with Achilles Tendinopathy, run by Spaulding Rehabilitation Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a randomized control trial with an elective cross over after three months to evaluate three different treatments in the management of non-insertional Achilles Tendinopathy. The treatment methods include physical therapy, shockwave therapy and photobiomodulation. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Achilles Tendinopathy
What is being tested?
Shockwave Therapy, Photobiomodulation Therapy and Physical Therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteUnited States
Study dates
29 Aug 2022to 1 Oct 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • A diagnosis of mid-portion Achilles tendinopathy (including both unilateral and bilateral)
  • Running is the pre-injury primary form of physical activity and pre-injury would complete on average 10 miles per week or more of running
  • VISA-A <80 at baseline to be eligible

Who cannot join

  • Less than 3 months of symptoms
  • Primary insertional Achilles tendinopathy
  • Diagnosis of rheumatological disease/connective tissue condition, symptomatic arthritis of foot and ankle, a primary running related injury outside Achilles tendinopathy, other contraindications to PBMT or SWT
  • Have received SWT within the past 3 months to their Achilles
  • Prior injection within 3 months
  • Currently enrolled in PT for more than 4 weeks for their condition
Show all 9Show fewer
  • Women who are pregnant.
  • known history of Achilles tendon tear
  • currently taking oral steroid or fluoroquinolone class of antibiotics

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Spaulding Hospital Cambridge

    Cambridge, Massachusetts, 02138

Other trials in United States

About this study

Official title: Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, a Combination of Shockwave Therapy and Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy: A Randomized Control Trial With Elective Cross-Over Design

This is a randomized control trial with an elective cross over after three months to evaluate three different treatments in the management of non-insertional Achilles Tendinopathy. The treatment methods include physical therapy, shockwave therapy and photobiomodulation.

Read the detailed description

This is a randomized control study with an elective cross over. In part 1 of the study participants will be randomized into one of three treatment arms: 1) physical therapy only; 2) physical therapy and shockwave therapy; 3) physical therapy, shockwave therapy and photobiomodulation. At 3 months, patients can choose to switch to a different treatment arm than they were initially randomized.

Being tested
Shockwave Therapy, Photobiomodulation Therapy, Physical Therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Shockwave TherapyDevice

    Participants will receive shockwave therapy once a week for three weeks

  • Photobiomodulation TherapyDevice

    Participants will receive photobiomodulation therapy twice a week for three weeks

  • Physical TherapyOther

    Participants will enroll in physical therapy and complete an at-home exercise protocol

Study groups in NCT04725513
Study groupRoleWhat they receive
Physical Therapy OnlyActive comparatorNot described
Receives: Other: Physical Therapy
Shockwave Therapy and Physical TherapyExperimentalNot described
Receives: Device: Shockwave Therapy; Other: Physical Therapy
Photobiomodulation, Shockwave Therapy and Physical TherapyExperimentalNot described
Receives: Device: Shockwave Therapy; Device: Photobiomodulation Therapy; Other: Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Calf Raises Performed to Fatigue and Inability to Continue

    Calf raises performed to fatigue and inability to continue

    Measured: Difference from 0-3 months

  2. Ultrasound Measurements in Change of Cross Sectional Area

    Changes in the cross-sectional area measured on ultrasound

    Measured: Difference from 0-3 months

  3. Victorian Institute of Sports Assessment (VISA-A) Questionnaire

    Victorian Institute of Sports Assessment Questionnaire. The score of the questionnaire ranges from 0-100, where 100 is a person who is completely asymptomatic (better).

    Measured: change from baseline to 3 month follow-up measure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2021
  2. Study start29 Aug 2022
  3. Primary completion1 Sep 2024
  4. Study completion1 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
The first part of the study is a randomized control trial, the second part is an elective cross over
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04725513
Sponsor's protocol ID
2021P000025
Status last verified
Jan 2026
First submitted
14 Jan 2021
Last updated
12 Jan 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Tenforde AS, Pham L, Gaudette LW, Funk MM, Vogel KE, Bruneau MM, Yuan X, Schroeder JD, Isaacson B, Hagar N, Metzger E, Nolan DC, Tam J, Silbernagel KG. Exercise, radial pressure waves, and photobiomodulation for management of non-insertional Achilles tendinopathy in runners: a three-arm non-blinded randomised control trial. BMJ Open Sport Exerc Med. 2025 Oct 5;11(4):e002442. doi: 10.1136/bmjsem-2024-002442. eCollection 2025.

    PubMed 41070206
  • Tenforde AS, Vogel KEL, Tam J, Silbernagel KG. Research protocol to evaluate the effectiveness of shockwave therapy, photobiomodulation and physical therapy in the management of non-insertional Achilles tendinopathy in runners: a randomised control trial with elective cross-over design. BMJ Open Sport Exerc Med. 2022 Sep 27;8(3):e001397. doi: 10.1136/bmjsem-2022-001397. eCollection 2022.

    PubMed 36187084

Questions about this trial

What is this clinical trial studying?

A study testing Shockwave Therapy, Photobiomodulation Therapy and Physical Therapy in people with Achilles Tendinopathy, run by Spaulding Rehabilitation Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 12 Jan 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Calf Raises Performed to Fatigue and Inability to Continue (time frame: Difference from 0-3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04725513, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in